1363380-75-9 Usage
Uses
Used in Organic Synthesis:
Methyl 3-Boc-3-azabicyclo[3.1.1]heptane-6-carboxylate is utilized as a building block in organic synthesis for the preparation of various biologically active molecules, pharmaceuticals, and natural products. Its unique structure and functional groups make it a valuable component in creating complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, Methyl 3-Boc-3-azabicyclo[3.1.1]heptane-6-carboxylate is used as a key intermediate in the development of drugs. Its potential pharmacological applications have been explored, particularly for the treatment of neurological and psychiatric disorders. Methyl 3-Boc-3-azabicyclo[3.1.1]heptane-6-carboxylate's ability to be modified and incorporated into various drug structures makes it a versatile tool in medicinal chemistry.
Used in Medicinal Chemistry Research:
Methyl 3-Boc-3-azabicyclo[3.1.1]heptane-6-carboxylate is also employed in medicinal chemistry research to study its properties and potential applications. Researchers use Methyl 3-Boc-3-azabicyclo[3.1.1]heptane-6-carboxylate to investigate its interactions with biological targets and evaluate its efficacy in treating specific conditions, contributing to the advancement of drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1363380-75-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,3,3,8 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1363380-75:
(9*1)+(8*3)+(7*6)+(6*3)+(5*3)+(4*8)+(3*0)+(2*7)+(1*5)=159
159 % 10 = 9
So 1363380-75-9 is a valid CAS Registry Number.
1363380-75-9Relevant academic research and scientific papers
Nitrogen-containing heterocyclic derivative and preparation thereof
-
Paragraph 0264; 0268-0272, (2021/05/12)
The invention discloses a nitrogen-containing heterocyclic compound as shown in a formula (I), a stereoisomer, a solvate, a metabolite, a pharmaceutically acceptable salt, a co-crystal or a prodrug of the nitrogen-containing heterocyclic compound, a pharmaceutical composition of the nitrogen-containing heterocyclic compound, a preparation method of the nitrogen-containing heterocyclic compound, and an application of the nitrogen-containing heterocyclic compound in prevention and treatment of autotaxin mediated diseases.
